30 Sept 2026, 17:29
Substantial Holders—
MAPMICROBA LIFE SCIENCES LIMITED
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 08:42
Company AdministrationMS
22 Sept 2026, 09:25
OtherMS
31 Aug 2026, 12:34
Financial ResultsMS
31 Aug 2026, 11:57
Company Administration—
31 Aug 2026, 11:57
Company Administration—
26 Aug 2026, 09:30
OtherMS
31 July 2026, 15:05
Director Interests—
31 July 2026, 15:03
Director Interests—
29 July 2026, 17:20
Capital Raising—
29 July 2026, 10:38
Securities Administration—
29 July 2026, 10:38
Securities Administration—
29 July 2026, 10:38
Securities Administration—
29 July 2026, 10:38
Securities Administration—
29 July 2026, 10:27
Securities Administration—
28 July 2026, 09:39
Capital Raising—
24 July 2026, 17:29
Meetings & Governance—
20 July 2026, 09:04
Company Update—
16 July 2026, 09:12
PresentationsMS
16 July 2026, 09:03
Quarterly ReportsMS
14 July 2026, 16:36
Substantial Holders—
14 July 2026, 12:09
Presentations—
23 June 2026, 16:07
Substantial Holders—
23 June 2026, 16:04
Meetings & Governance—
19 June 2026, 17:01
Substantial Holders—
19 June 2026, 09:14
Securities Administration—
19 June 2026, 09:12
Capital Raising—
19 June 2026, 09:09
Meetings & GovernanceMS
18 June 2026, 10:08
Securities Administration—
12 June 2026, 09:46
ReinstatementMS
12 June 2026, 09:46
Securities Administration—
12 June 2026, 09:46
Securities Administration—
12 June 2026, 09:46
Securities Administration—
12 June 2026, 09:46
Securities Administration—
12 June 2026, 09:46
PresentationsMS
12 June 2026, 09:45
Capital RaisingMS
11 June 2026, 08:45
Other—
5 June 2026, 09:39
Trading Halt / SuspensionMS
3 June 2026, 10:00
Trading Halt / SuspensionMS
3 June 2026, 09:49
Trading Halt / SuspensionMS
30 Apr 2026, 17:52
Securities Administration—
30 Apr 2026, 09:17
PresentationsMS
30 Apr 2026, 09:12
Quarterly ReportsMS
28 Apr 2026, 14:26
Presentations—
26 Feb 2026, 09:05
Financial ResultsMS
29 Jan 2026, 09:23
PresentationsMS
29 Jan 2026, 09:21
Quarterly ReportsMS
22 Jan 2026, 09:19
Presentations—
3 Dec 2025, 08:50
Company AdministrationMS
21 Nov 2025, 17:14
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 17:29 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 Sept 2026, 08:42 | Appointment of Interim Chief Executive Officer | Company Administration | MS | 12008, 12019 | |
| 22 Sept 2026, 09:25 | GSS and MAP agree to Commercial Terms for Merger | Other | MS | — | |
| 31 Aug 2026, 12:34 | 2026 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 31 Aug 2026, 11:57 | 2026 Appendix 4G | Company Administration | — | 03025 | |
| 31 Aug 2026, 11:57 | 2026 Corporate Governance Statement | Company Administration | — | 03024 | |
| 26 Aug 2026, 09:30 | GSS: Genetic Signatures and Microba in Merger Discussions | Other | MS | — | |
| 31 July 2026, 15:05 | Change of Director's Interest Notice - Pasquale Rombola | Director Interests | — | 02009 | |
| 31 July 2026, 15:03 | Change of Director's Interest Notice - Prof Ian Frazer | Director Interests | — | 02009 | |
| 29 July 2026, 17:20 | Cleansing Notice | Capital Raising | — | 06003, 06017, 06018 | |
| 29 July 2026, 10:38 | Notification regarding unquoted securities - MAP | Securities Administration | — | 06021 | |
| 29 July 2026, 10:38 | Notification regarding unquoted securities - MAP | Securities Administration | — | 06021 | |
| 29 July 2026, 10:38 | Application for quotation of securities - MAP | Securities Administration | — | 06020 | |
| 29 July 2026, 10:38 | Notification regarding unquoted securities - MAP | Securities Administration | — | 06021 | |
| 29 July 2026, 10:27 | Application for quotation of securities - MAP | Securities Administration | — | 06020 | |
| 28 July 2026, 09:39 | Completion of Share Purchase Plan | Capital Raising | — | 06003, 06017 | |
| 24 July 2026, 17:29 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 20 July 2026, 09:04 | Microba signs multi-year SYNLAB agreement | Company Update | — | 11001 | |
| 16 July 2026, 09:12 | Q4 FY26 Quarterly Investor Presentation & Webinar | Presentations | MS | 03026, 14014, 19009 | |
| 16 July 2026, 09:03 | Q4 FY26 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 14 July 2026, 16:36 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 14 July 2026, 12:09 | Details of Q4 FY26 Quarterly Report, Appendix 4C & Webinar | Presentations | — | 03027, 14014 | |
| 23 June 2026, 16:07 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 23 June 2026, 16:04 | Letter to Shareholders, Notice of EGM & Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 19 June 2026, 17:01 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 19 June 2026, 09:14 | Cleansing Notice | Securities Administration | — | 06018 | |
| 19 June 2026, 09:12 | Letter to SPP Eligible Shareholders | Capital Raising | — | 06017, 08006, 16002 | |
| 19 June 2026, 09:09 | Disclosure Document - Prospectus | Meetings & Governance | MS | 06010, 08006 | |
| 18 June 2026, 10:08 | Application for quotation of securities - MAP | Securities Administration | — | 06020 | |
| 12 June 2026, 09:46 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 12 June 2026, 09:46 | Proposed issue of securities - MAP | Securities Administration | — | 06013 | |
| 12 June 2026, 09:46 | Proposed issue of securities - MAP | Securities Administration | — | 06013 | |
| 12 June 2026, 09:46 | Proposed issue of securities - MAP | Securities Administration | — | 06013 | |
| 12 June 2026, 09:46 | Proposed issue of securities - MAP | Securities Administration | — | 06013 | |
| 12 June 2026, 09:46 | Investor presentation - path to cashflow breakeven | Presentations | MS | 03026 | |
| 12 June 2026, 09:45 | $5M secured to deliver cashflow breakeven and testing growth | Capital Raising | MS | 06003, 06017, 14014 | |
| 11 June 2026, 08:45 | Extension of Voluntary Suspension | Other | — | 11003 | |
| 5 June 2026, 09:39 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 3 June 2026, 10:00 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 3 June 2026, 09:49 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 30 Apr 2026, 17:52 | Notification of cessation of securities - MAP | Securities Administration | — | 06027 | |
| 30 Apr 2026, 09:17 | Q3 FY26 Quarterly Investor Presentation & Webinar | Presentations | MS | 03026, 14014, 19008 | |
| 30 Apr 2026, 09:12 | Q3 FY26 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 14:26 | Details of Q3 FY26 Quarterly Report, Appendix 4C & Webinar | Presentations | — | 03027, 14014 | |
| 26 Feb 2026, 09:05 | Appendix 4D & FY26 Interim Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 29 Jan 2026, 09:23 | Q2 FY26 Quarterly Investor Presentation & Webinar | Presentations | MS | 03026, 14014 | |
| 29 Jan 2026, 09:21 | Q2 FY26 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 22 Jan 2026, 09:19 | Details of Q2 FY26 Quarterly Report, Appendix 4C & Webinar | Presentations | — | 03027, 14014 | |
| 3 Dec 2025, 08:50 | Microba receives $3 million R&D Tax Incentive Refund | Company Administration | MS | 12008 | |
| 21 Nov 2025, 17:14 | Release of Restricted Securities | Securities Administration | — | 06009 |
1–50 of 83
1 / 2